See also this year's filing and all EDGAR filings for this company.
PDF Report 0000316253_2013_ENZO_Biochem_INC.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 0.008121497604158206, 'aggregate_val': 24826000, 'exp_sum': 24626000, 'exp_to_value': {'LongTermLiabilities': 774000, 'LiabilitiesCurrent': 23852000, 'remainder_Liabilities': 0}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000316253, ENZO Biochem INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 19,232,000 |
| 1 | AssetsNonCurrent | 407,000 |
| 2 | AssetsCurrent | 40,368,000 |
| 3 | PropertyPlantAndEquipment | 9,116,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 18,956,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 47,928,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 6,293,000 |
| 16 | remainder_Expenses | 87,689,000 |
| 17 | remainder_Revenues | 103,083,000 |
| 18 | remainder_NetIncome | -442,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 69,123,000 |
| 1 | Liabilities | 18,956,000 |
| 2 | Expenses | 141,910,000 |
| 3 | Revenues | 103,083,000 |
| 4 | StockholdersEquity | 50,167,000 |
| 5 | NetIncome | -39,269,000 |
| 6 | ComprehensiveNetIncome | -39,269,000 |
| 7 | BaseVar | 166,757,000 |
| 8 | EconomicCapitalRatio | 2.28 |
Edgar->Model Mapping
Feature Distribution
